{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T18:02:38Z","timestamp":1785175358987,"version":"3.55.0"},"reference-count":30,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background\/Objectives: Pulmonary hemorrhage (PH) is a life-threatening complication of prematurity associated with patent ductus arteriosus (PDA). Whether PDA treatment timing reduces PH risk remains uncertain because treatment strategies reflect underlying illness severity. We examined PH risk across recorded PDA treatment strategy categories in a national very low birth weight (VLBW) cohort. Methods: We analyzed Korean Neonatal Network (KNN) registry data (2013\u20132024) using propensity score inverse probability weighting (IPW) to compare recorded PDA treatment strategies among VLBW infants. Sensitivity analyses addressed treatment-opportunity bias, temporal confounding, and positivity violations. Results: Among 23,500 VLBW infants, 1179 (5.0%) developed PH. PH rates were 4.5% (pre-symptomatic), 10.0% (symptomatic treated), 12.3% (symptomatic untreated), 9.9% (prophylactic), and 2.3% (asymptomatic untreated). In IPW analyses, pre-symptomatic treatment consistently showed lower PH risk versus symptomatic treatment (OR 0.57, 95% CI 0.46\u20130.72) and symptomatic untreated PDA (OR 0.51, 95% CI 0.39\u20130.66), across sensitivity analyses. Prophylactic treatment showed higher PH risk than pre-symptomatic treatment (OR 1.97, 95% CI 1.31\u20132.96) and did not differ from symptomatic treatment. Subgroup analyses showed stronger associations in moderately preterm infants, with significant effect modification by gestational age (interaction p = 0.011) and birth weight (interaction p = 0.007). Conclusions: In this national VLBW cohort, infants with a recorded pre-symptomatic PDA treatment strategy had lower observed pulmonary hemorrhage rates compared with those receiving symptomatic treatment, after propensity score adjustment. Prophylactic treatment was not associated with lower PH risk compared with symptomatic treatment but showed higher PH risk than pre-symptomatic treatment. Given the observational design and absence of PH event timing data, causal inferences cannot be drawn. These hypothesis-generating findings support prospective evaluation of risk-based, pre-symptomatic PDA treatment strategies and do not support universal prophylaxis as a pulmonary hemorrhage prevention measure in VLBW infants.<\/jats:p>","DOI":"10.3390\/children13080991","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:16:34Z","timestamp":1785172594000},"page":"991","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PDA Treatment Strategy and Pulmonary Hemorrhage Risk in Very Low Birth Weight Infants: A Nationwide Cohort Study"],"prefix":"10.3390","volume":"13","author":[{"given":"Ju Ae","family":"Shin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1444-6495","authenticated-orcid":false,"given":"Moon-Yeon","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sahussarungsi, S., Lapointe, A., Villeneuve, A., Hebert, A., Nouraeyan, N., Lakshminrusimha, S., Singh, Y., Sabapathy, C., Cavall\u00e9-Garrido, T., and Sant\u2019anna, G. (2025). Pulmonary Hemorrhage in Premature Infants: Pathophysiology, Risk Factors and Clinical Management. Biomedicines, 13.","DOI":"10.20944\/preprints202506.2090.v1"},{"key":"ref_2","first-page":"CD005254","article-title":"Surfactant for pulmonary haemorrhage in neonates","volume":"2","author":"Aziz","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_3","unstructured":"Shrestha, B.K., and Agarwal, A. (2026). Pulmonary Hemorrhage in Newborns. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000528914","article-title":"European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update","volume":"120","author":"Sweet","year":"2023","journal-title":"Neonatology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Arlettaz, R. (2017). Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants. Front. Pediatr., 5.","DOI":"10.3389\/fped.2017.00147"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e20201209","DOI":"10.1542\/peds.2020-1209","article-title":"Patent Ductus Arteriosus of the Preterm Infant","volume":"146","author":"Hamrick","year":"2020","journal-title":"Pediatrics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1542\/peds.94.5.719","article-title":"Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: A retrospective cohort study","volume":"94","author":"Garland","year":"1994","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S0022-3476(05)81233-8","article-title":"Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: An autopsy evaluation","volume":"120","author":"Long","year":"1992","journal-title":"J. Pediatr."},{"key":"ref_9","first-page":"21","article-title":"What is a hemodynamically significant PDA in preterm infants?","volume":"14","author":"Shepherd","year":"2019","journal-title":"Congenit Heart Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105977","DOI":"10.1016\/j.earlhumdev.2024.105977","article-title":"Analysis of perinatal risk factors for massive pulmonary hemorrhage in very low birth weight infant: A nationwide large cohort database","volume":"191","author":"Jung","year":"2024","journal-title":"Early Hum. Dev."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Park, K.H., Kim, E.Y., Cho, H.W., Jung, J.K., Kim, Y.S., and Choi, B.M. (2025). A decision tree analysis to predict massive pulmonary hemorrhage in extremely low birth weight infants: A nationwide large cohort database. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1529712"},{"key":"ref_12","first-page":"CD000174","article-title":"Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants","volume":"7","author":"Fowlie","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1542\/peds.2007-0028","article-title":"Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: Results from the trial of indomethacin prophylaxis in preterms","volume":"121","author":"Alfaleh","year":"2008","journal-title":"Pediatrics"},{"key":"ref_14","first-page":"CD004213","article-title":"Ibuprofen for the prevention of patent ductus arteriosus in preterm and\/or low birth weight infants","volume":"6","author":"Ohlsson","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_15","first-page":"CD003481","article-title":"Ibuprofen for the treatment of patent ductus arteriosus in preterm or low-birth-weight (or both) infants","volume":"2","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_16","first-page":"CD013588","article-title":"Interventions for patent ductus arteriosus (PDA) in preterm infants: An overview of Cochrane Systematic Reviews","volume":"4","author":"Mitra","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1001\/jama.2018.1896","article-title":"Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis","volume":"319","author":"Mitra","year":"2018","journal-title":"JAMA"},{"key":"ref_18","first-page":"CD010061","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"1","author":"Ohlsson","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3389\/fped.2019.00568","article-title":"Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis","volume":"7","author":"Xiao","year":"2020","journal-title":"Front Pediatr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpeds.2018.09.012","article-title":"PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age","volume":"205","author":"Clyman","year":"2019","journal-title":"J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJMoa2207418","article-title":"Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus","volume":"388","author":"Hundscheid","year":"2023","journal-title":"N Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa2305582","article-title":"Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen","volume":"390","author":"Gupta","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jamapediatrics.2025.1025","article-title":"Active Treatment vs Expectant Management of Patent Ductus Arteriosus in Preterm Infants: A Meta-Analysis","volume":"179","author":"Buvaneswarran","year":"2025","journal-title":"JAMA Pediatr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/pch\/pxab085","article-title":"Management of the patent ductus arteriosus in preterm infants","volume":"27","author":"Mitra","year":"2022","journal-title":"Paediatr. Child Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.2015.6734","article-title":"Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants","volume":"313","author":"Cambonie","year":"2015","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e2025071425","DOI":"10.1542\/peds.2025-071425","article-title":"Patent Ductus Arteriosus in Preterm Infants","volume":"155","author":"Ambalavanan","year":"2025","journal-title":"Pediatrics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3346\/jkms.2015.30.S1.S3","article-title":"The Korean Neonatal Network: An Overview","volume":"30","author":"Chang","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41372-024-01971-x","article-title":"Prophylactic indomethacin and the risk of serious pulmonary hemorrhages in preterm infants less than 28 weeks\u2019 gestation","volume":"44","author":"Clyman","year":"2024","journal-title":"J. Perinatol."},{"key":"ref_29","first-page":"CD013278","article-title":"Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants","volume":"6","author":"Mitra","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Shin, J., Lee, J.A., Oh, S., Lee, E.H., and Choi, B.M. (2021). Conservative Treatment Without Any Intervention Compared With Other Therapeutic Strategies for Symptomatic Patent Ductus Arteriosus in Extremely Preterm Infants: A Nationwide Cohort Study in Korea. Front. Pediatr., 9.","DOI":"10.3389\/fped.2021.729329"}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/8\/991\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:18:32Z","timestamp":1785172712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/8\/991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,26]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["children13080991"],"URL":"https:\/\/doi.org\/10.3390\/children13080991","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,26]]}}}